DBV Technologies Stock (NASDAQ: DBVT) stock price, news, charts, stock research, profile.
Open | $0.550 |
Close | - |
Volume / Avg. | 101.531K / 62.670K |
Day Range | 0.540 - 0.600 |
52 Wk Range | 0.420 - 2.370 |
Market Cap | $109.877M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | - |
Days to Cover | 9.76 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DBV Technologies (NASDAQ: DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: Anixa Biosciences (NASDAQ:ANIX), Curis (NASDAQ:CRIS), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for DBV Technologies (NASDAQ: DBVT) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 5.00 expecting DBVT to rise to within 12 months (a possible 734.72% upside). 6 analyst firms have reported ratings in the last year.
The stock price for DBV Technologies (NASDAQ: DBVT) is $0.599 last updated May 13, 2024 at 8:02 AM EDT.
There are no upcoming dividends for DBV Technologies.
DBV Technologies’s Q2 earnings are confirmed for Monday, July 29, 2024.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.